Hemp THC Policy: The U.S. House tucked a one-month delay into a continuing resolution, pushing the federal hemp THC restrictions from Nov. 12 to Dec. 11, giving retailers and brands a short holiday reprieve while lawmakers keep negotiating. Regulatory Compliance: New Mexico’s “seed-to-sale” tracking system (NMS2S) is causing major retailer losses after technical failures, including tens of thousands of items not transferring and mislabeling that blocks sales. Legal Pressure on Branding: The University of Maryland sent a cease-and-desist to Terps USA over the “Terps” name and logo, escalating trademark and naming fights in cannabis-adjacent products. Retail Operations: Platte City, Missouri approved changes letting its licensed dispensary operate 24/7, updating outdated local rules for the adult-use market. Enforcement & Supply Chain: Police in Osun, Nigeria seized suspected Indian hemp from an abandoned vehicle and arrested three suspects; in Koraput, India, police destroyed about 12,000 cannabis plants after catching farmers tending them. Industry Business: Curaleaf opened a new Boston store, but social equity advocates criticized the move as neighborhood “cannibalization” by a multi-state chain. Security Risk: An IDScan.net breach-linked marketplace is reportedly selling massive identity scan data, raising concerns for verification systems used across regulated industries, including cannabis.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Hemp Ban Delay: President Trump signed a stopgap bill pushing the federal hemp-derived THC ban from Nov. 12 to Dec. 11, buying businesses more time to build compliant rules. Regulatory Pressure: Lawmakers are still debating how to regulate hemp THC products instead of outright prohibition, with Michigan hemp firms calling the reprieve short-lived. Retail Expansion: Illinois dispensary Terrabis is rolling out drive-thru service after state law changes, signaling more convenience-focused cannabis retail. Workforce Reality Check: A new report flags a 54.6% budtender turnover rate in the U.S., with 23% leaving before their first full month—raising the stakes for better benefits and retention. Enforcement & Seizures: Police in Osun, Ghana, and the UK reported multiple busts involving suspected Indian hemp and cannabis-linked trafficking, while Canada’s Atlantic Institution seized hashish, shatter, tobacco, and vaping gear. Product/Brand News: The Hemp Doctor won “Best THC/CBD Beverage” at an ECRM tasting, highlighting continued momentum for hemp-derived drinks. Local Governance: California’s violence intervention program is credited with major firearm violence reductions over 14 years, reinforcing the prevention-first approach.
Federal Hemp THC Pause: Congress approved a 30-day delay on most federal restrictions for hemp-derived THC products, pushing the effective date from Nov. 12 to Dec. 11, while synthetic cannabinoids stay on the original timeline—sparking relief and uncertainty for retailers and breweries. State Enforcement & Recalls: Missouri’s Division of Cannabis Regulation issued a recall for certain products from GF Extraction Lab LLC after finding cannabinoids made via chemical modification/conversion/synthetic derivation; consumers are told to stop using and return/discard. Retail Impact From New Rules: Virginia’s hemp sellers face major losses after new restrictions took effect, with one retailer claiming most inventory became noncompliant and could force closures. Local Cannabis Policy Moves: San Diego County supervisors approved a cannabis policy update, while Nebraska leaders pushed changes to petition circulator rules amid broader regulatory politics. Industry Watch: Minnesota THC drink makers and shops say the delay helps, but the looming federal deadline still threatens jobs and product lines. Criminal Justice Spillover: Multiple drug enforcement stories dominated the week, including meth trafficking cases and money-laundering raids, underscoring the wider enforcement pressure around cannabinoids and hemp-adjacent markets.
Hemp THC policy shift: The U.S. House and President Trump signed a stopgap funding bill that delays most federal hemp-derived THC restrictions until Dec. 11 (from Nov. 12), giving lawmakers more time to craft rules instead of prohibition. Regulation vs. prohibition debate: An op-ed argues the next few months will decide whether hemp THC products get workable regulation or get squeezed out. Ghana research push: NACOC and CSIR are teaming up to advance low-THC (≤0.3%) cannabis research, with tighter oversight, lab testing, and traceability. Industry finance: POSaBIT amended its loan with Perga Capital Partners, accelerating principal repayment while extending maturity and lowering interest. Security and identity risk: A reported breach on a Russian cybercrime forum offered access to 153M+ U.S./Canadian driver’s licenses, including scans tied to cannabis dispensary age checks. Enforcement headlines: Nigeria Customs handed over cannabis and other drugs plus mercury worth N3.95bn to NDLEA/NESREA; Ghana and other regions also reported cannabis seizures and eradication. Workplace organizing: Cannabis workers at Tacoma’s The Herbal Gardens continue bargaining for a first union contract after months of stalling. Local cannabis business progress: A Maryland dispensary plan in Pocomoke City cleared planning review and eyes construction this fall.
Hemp Policy Shockwave: Congress passed a stopgap bill that delays the federal hemp THC ban until Dec. 11, giving hemp-derived beverage and edible makers a short runway to keep selling while regulators finalize rules. Regulatory & Compliance: San Diego County supervisors (3-2) formally approved a “socially equitable” cannabis policy for unincorporated areas, expanding cultivation, distribution, manufacturing, retail and testing under new zoning limits and fees. Retail Expansion: JARS Cannabis acquired Arizona craft brand Sonoran Roots, with all Ponderosa locations slated to transition into JARS over time. Public Safety & Enforcement: New Jersey cracked down on retailers accused of selling tobacco and THC products to minors, while multiple international drug cases highlighted ongoing cannabis trafficking pressure. Product Safety: FDA reported a recall of Broadway Joe’s CBD pain cream due to potential contamination of raw material. Corporate Moves (ASX): Elixinol Wellness received a binding offer for its U.S. business sale; Little Green Pharma confirmed a new group finance lead; Zelira Therapeutics was suspended from official quotation over unpaid listing fees.
Federal Hemp Policy: The U.S. House passed a continuing resolution that delays the federal ban on most hemp-derived THC products until Dec. 11, sending it to President Trump’s desk and giving hemp businesses and farmers more time to push for a long-term regulatory fix. State Enforcement: California reported major progress in cracking down on unlicensed and risky products, citing high compliance rates and thousands of hemp and kratom/7-OH products removed from store shelves, alongside a large illicit warehouse seizure. Market & Money: California also highlighted nearly $8.4B in marijuana tax revenue since legalization, while Curaleaf and Aurora traded barbs in a shareholder fight over value and strategy. Health Watch: CDC data flagged a sharp rise in emergency visits tied to cannabis hyperemesis syndrome after a new diagnostic code, and new research linked frequent cannabis use with higher morning cortisol. Industry Operations: Muha Meds promoted cannabis verification to fight counterfeit vape packaging, while local cannabis retail stories included a new dispensary opening in St. Peter and a proposed California drive-thru dispensary bill put on hold.
Hemp Policy Shockwave: The U.S. House approved a stopgap funding bill that delays the hemp-derived THC product ban by one month, buying Minnesota’s hemp beverage makers more time while the measure heads to the White House. Regulatory Pressure on “Hemp” Claims: Alabama’s Opelika revoked a store’s business license after state lab testing found products sold as hemp flower were actually marijuana, a Schedule One controlled substance. Courtroom Crackdown: In Zambia, a magistrate convicted Henry Shula Kasolo for paying K60,000 to DEC officers to move a cannabis consignment, while another case saw Henry Mumba sentenced after trafficking psychotropic substances including cannabis. Industry Safety Spotlight: Oklahoma’s cannabis extraction debate heats up after a deadly explosion at a processor raised questions about solvent safety and oversight. Market/Business Moves: Australian medicinal cannabis names saw mixed investor narratives, including Bioxyne’s record revenue and guidance upgrade, while Vitura Health’s platform model faces tighter prescribing rules. Enforcement Watch: Police operations in places like South Australia targeted drug activity around major hubs, including cannabis and meth detections.
Federal Hemp/THC Policy Fight: The House passed a stopgap funding bill to keep the government running through Dec. 11, but lawmakers split over added provisions, including a delay on a ban for intoxicating hemp products—setting up more GOP infighting and a potential floor fight. Public Health & Safety: A new study finds kids’ accidental edible drug ingestions jumped 3,307% from 2000–2024, with cannabinoids driving most cases and edible marijuana a major share. CBD/Anxiety Research: A roundup on cannabidiol for anxiety highlights encouraging findings since 2020 while stressing the evidence limits for real-world treatment. Industry/Operations Risk: A THC extraction facility explosion in Oklahoma killed two people, and the owner faces murder charges amid claims about ventilation, licensing, and compliance failures. Law Enforcement & Crime: Police charged multiple people in connection with a moorland fire at Dovestone, including cannabis-linked charges for some suspects. Retail/Community Signals: New England retailers say more towns are rejecting “generational tobacco” style policies at public votes, a reminder that local governance can swing health rules.
Regulatory Compliance & Retail: Clubhouse Drops says its hemp-derived e-commerce is built around third-party lab testing, age verification, and strict “no-ship” rules for jurisdictions where products are prohibited. Medicinal Cannabis Market Watch (Australia): ASX cannabis stocks stayed in focus as Cann Group highlighted ongoing licensed cultivation/manufacturing buildout, while Neurotech framed a cannabinoid medicine path through conventional drug trials; Vitura Health leaned on its telehealth-driven marketplace model, and Little Green Pharma kept European supply and pharmacy distribution central. Public Health & Product Safety: California Gov. Newsom signed AB 2249 to tighten cannabis packaging/labeling rules deemed “attractive to children,” including clearer triggers like cartoons and kid-focused imagery. State Cannabis Access (US): Maine will distribute 12,000 lockable cannabis storage bags to retailers and public health advocates, aiming to keep products out of reach of kids and pets. Enforcement & Crime: A Lancashire prison death report says an EncroChat dealer allegedly earning £500k every two months continued drug activity behind bars; in Saskatchewan, RCMP seized cocaine, cannabis, and 52,500 unstamped cigarettes in a Pilger raid. Industry Disruption: Oklahoma investigators report a deadly cannabis facility explosion tied to THC extraction operations, with the owner later arrested on murder charges.
DEA Scheduling: The DOJ/DEA moved three kratom-related, opioid-like compounds into Schedule I on an emergency basis for two years, targeting products sold in gas stations and smoke shops. Public Safety & Enforcement: Pennsylvania’s grand jury warned that unregulated smoke shops are selling illegal THC products marketed as hemp, calling for tighter oversight and legislative fixes. Rescheduling Watch: A new look at federal rescheduling says Schedule III could open another path for hemp beverages if Congress follows through—though the recreational question is still in play. CBD for Pets: A vet-focused report urges caution: dog CBD may have promise, but research is limited and many OTC products aren’t held to the same safety standards as approved meds. Campus Prevention: Ghana’s NACOC chief called for stronger coordination with universities to prevent drug abuse on campus, emphasizing counseling and early support. Hemp Industry Pressure: Kentucky’s governor pushed back on a planned hemp THC product ban, warning it could “decimate” the hemp industry. Cannabis in the Courts: Ireland saw a remand fight after a cannabis case stalled over missing prosecution materials, while Dublin heard a cocaine “handover” linked to organized crime. Research: JAMA Network Open reported THC edibles impair simulated driving in a dose-dependent way, even below common roadside enforcement thresholds.
Cannabis Stocks Watch: Australia’s Avecho (ASX:AVE) is leaning into the US recreational market by licensing its delivery tech, while Neurotech (ASX:NTI) is back in focus for paediatric cannabinoid trials and autism; Cann Group (ASX:CAN) is also under the spotlight as it works through cultivation capacity built for a slower-than-expected medicinal ramp, and Little Green Pharma (ASX:LGP) remains the standout exporter leaning on Europe. Regulation & Policy: Missouri’s intoxicating hemp ban is again defended in federal court as industry argues it’s unconstitutional, and New York’s legal weed ecosystem faces new “screw up” concerns. Road Safety & Enforcement: Perth ran a major impaired-driving crackdown, testing thousands for alcohol and drugs, while multiple jurisdictions reported drug-related arrests and seizures. Supply Chain & Crime: Nigeria’s NDLEA seized over N4.6bn in abandoned import drugs at Lagos airport, and separate operations flagged large “Jihadi drug” consignments. Consumer Access: New York State Fair debuted a cannabis consumer advocacy booth, pushing for more consumer data and safety/quality focus. Business & Community (Non-CBD): A Melbourne “missing middle” townhouse push targets first-home buyers and downsizers with low-maintenance infill near transport and amenities.
Cannabinoid Retail Rules: A new wave of “cannabinoid combinations” is reshaping how shoppers pick products, with brands pairing CBD/THC and minor cannabinoids to target specific effects—so labels now matter more than ever. Strain Naming Chaos: A fresh look at cannabis strain names says there’s no registry or authority, leaving breeders and marketers to shape “genetics” branding with little real standardization. Legal Hemp Fight: Missouri’s intoxicating hemp ban is headed to federal review, with the Missouri Hemp Trade Association arguing overlapping definitions make the law unclear and ripe for a constitutional challenge. Drug Enforcement (Global): Nigeria’s NDLEA reported major Captagon (“Jihadi drug”) and opioid seizures at Lagos airport, while police in Dublin charged two men after a €2.3m cocaine handover, also netting MDMA and cannabis. Public Safety & Crime: Anambra police arrested a suspected dealer and seized ₦5.8m in cannabis, meth and “Colorado,” as authorities push tougher election-period crackdowns. Health Policy (Psychedelics): New Mexico opened medical psilocybin producer permit applications, moving the program toward operational rollout.
Hemp retail crackdown (US): A Wisconsin hemp shop owner says his arrest over alleged illegal THC sales was racially motivated, arguing his products stayed within the state’s 0.3% delta-9 dry-weight rule; the case has disrupted staff and forced compliance changes. Local zoning (US): East Ridge, Tennessee, moved to regulate vape, tobacco, and cannabinoid specialty shops with “use on review” approval plus distance limits from schools and other specialty stores. Court fight over hemp definitions (US): Missouri is facing a federal challenge over whether its “intoxicating hemp” ban is clear enough, with plaintiffs arguing the state uses overlapping definitions that make products simultaneously “hemp” and “marijuana.” Medical cannabis expansion (US): Alabama opened its second medical cannabis dispensary in Talladega to improve patient access and reduce travel burdens. Research (CBD/THC): A new study reports ultra-low-dose THC treatment may push breast cancer organoids toward less aggressive behavior by targeting the endocannabinoid system. Enforcement (global): Police in Tobago seized $1.1M in cannabis and arrested three; Ireland reported a €2.3M cocaine/cannabis/MDMA bust; Nigeria’s Anambra police recovered ₦5.8M in cannabis and meth.
Regulatory Push (Ireland): Ireland’s Public Health and Justice ministers set up a joint working group to respond fast to synthetic cannabinoids after HSE lab tests found high-risk compounds in vapes, vape liquids, and edible products, with severe harms flagged—especially for young people. Enforcement (Nigeria): Anambra police arrested a 28-year-old suspected dealer and seized cannabis, methamphetamine, and “Colos” worth about ₦5.8m, with investigators probing links to election disruption. Enforcement (Ireland): Gardaí in Dublin seized nearly €2.3m in suspected cocaine, cannabis, and MDMA after an intelligence-led handover in Blanchardstown, arresting two men in their 50s and 60s; follow-up searches added 5,000 MDMA tablets. Hemp Retail Impact (US): An Illinois hemp retailer, RiverBluff Collective, plans to close its East Dubuque storefront after Nov. 11 as federal hemp definitions change, while its licensed cannabis dispensary location stays open. Market Signal (US): A Gallup poll says more Americans now report smoking cannabis than cigarettes, reinforcing cannabis’s continued mainstream momentum.
Synthetic Cannabinoids Crackdown (Ireland): Ireland’s Public Health and Justice ministers set up a joint working group to tackle synthetic and semi-synthetic cannabinoids after HSE lab tests found high-risk compounds in vapes, vape liquids, and edibles, with officials warning of severe intoxication and psychosis risks—especially for young people. Public-Sector Drug Testing (Ghana): Interior Minister Mohammed Mubarak Muntaka says the government is preparing a Cabinet paper to make drug testing mandatory for public service recruits after thousands were disqualified in security recruitment screening. Hemp/THC Legal Battle (Texas): A Texas judge could soon allow hemp businesses to sell THC products again via a temporary restraining order, as “Total THC” rules face ongoing court fights. THC Drink Limits (Florida): Florida hemp industry groups are urging Congress to rethink federal THC drink limits that could wipe out many THC beverages and gummies starting in November. Medical Cannabis Expansion (Alabama): Alabama opened a second medical cannabis dispensary in Talladega County, with more launches expected soon. CBD Research Push (Dogs/Cancer): Cannabis for Cancer Declaration is seeking partners for controlled cannabinoid trials in dogs after a systematic review highlighted CBD’s potential antitumor effects in canine oncology. Compliance & Safety (Vapes/Youth): Multiple reports highlight ongoing concerns about what’s actually inside vapes and the harm from unregulated or mislabeled products.
Organized Crime & Laundering: New Zealand prosecutors say Vietnamese syndicates used front businesses (construction, beauty, hospitality) to launder cannabis profits, fund visas, and run “ever-increasing” grow operations. Legal Market Growth: Canada hit a new high in legal cannabis retail, with June sales at $517.8M and dispensaries outpacing liquor stores in some areas. Bankruptcy Access: A U.S. court recognized The Cannabist Company’s Canadian restructuring under Chapter 15, signaling a path for cannabis firms to use federal protections more than before. Regulatory & Transparency Fight: St. Maarten lawmakers spar over a Native Nations cannabis deal, with critics calling the concession “sneaky” and questioning exclusivity, documents, and financial exposure. Medical Cannabis M&A: UK medicinal supplier Grow Group is reportedly seeking new owners via advisers as it prepares a sale process. Public Health Alarm: UK reports warn of cannabis sprayed with synthetic opioids like nitazenes, raising overdose concerns. Enforcement: Hong Kong Customs seized ~32kg of suspected cannabis worth ~$7.5M at the airport, arresting a British transit passenger. Industry Compliance: Guam’s cannabis board discussed delivery rules after a hemp/cannabis operator asked for written guidance.
Cross-Border Enforcement: RCMP says two Air Canada ground employees were arrested over an alleged scheme to move luggage through Montréal-Trudeau secure areas—importing cocaine and exporting cannabis after CBSA intercepted 62.5kg cocaine and seized 56kg cannabis. Retail Compliance Push: CSP C-Store Cannabis Board partnered with Element Training to expand hemp/cannabis education for convenience-store teams, focusing on product knowledge, ID checks, and state-by-state rules. Parliament Transparency Fight: St Maarten MPs rejected a motion demanding full disclosure of the Native Nations Cannabis agreement, with debate centered on what was signed and potential financial exposure. Major Drug Bust: Penang police dismantled three syndicates after raids netted RM3.2m in drugs, including cannabis buds/powder, meth, ketamine, ecstasy pills, and Erimin 5 tablets. Public Health Warning: A study found unintentional recreational-drug ingestions by young children surged 3,307% from 2000 to 2024, with big jumps tied to edible marijuana and psilocybin products. Local Cannabis Crackdown: New York’s OCM issued a cease-and-desist to an unlicensed cannabis store in New Rochelle.
Policy Shake-Up: Czech PM Andrej Babiš dismantled the country’s long-running drug-policy coordination office, triggering alarm from addiction experts and providers who say the 20-year approach is being undone. Vaping Crackdown: California advanced a bill to ban disposable vape pens with embedded batteries (cannabis devices exempt), citing toxic litter and public costs. Hemp/THC Rules: Virginia hemp firms are pushing lawmakers for a hearing after new THC product limits removed a prior CBD-to-THC ratio allowance, with lawsuits already underway. CBD/Health Research: A THC-free oral CBD therapy (CardiolRx) showed reduced chest pain and inflammatory markers in recurrent pericarditis patients, per JAMA Heart Association data. Regulation Watch: Ireland’s HSE tested 76 HHC vapes; 28 contained HHC, renewing calls to keep them away from under-18s. Industry Finance: Safe Harbor says cannabis banking infrastructure is scaling up as federal rescheduling activity continues, highlighting compliance-heavy program design. Enforcement: Major cross-border raids in Ireland/NI seized €1.6m cannabis plus imitation firearms; elsewhere, HHC vapes and cannabis grow operations keep drawing police action.
WHO Update: The World Health Organization has updated its cannabis risk assessment for the first time in a decade, warning that higher-THC products and newer consumption patterns are driving increased harms—especially for adolescents and young adults. Health & Safety: A new meta-analysis links cannabis use with earlier psychosis onset, averaging about 2.5 years sooner than nonusers. Regulatory Pressure: North Carolina is weighing expanded toxicology testing for marijuana-impaired driving, but officials say enforcement is hard without a clear roadside standard. Legal & Enforcement: Korea Customs says a second mail screening line has uncovered 10 more narcotics cases and led to arrests. Market Watch: Thailand’s cannabis market is contracting, and Four Twenty is launching Project Atlas to lock in long-term farm partnerships with structured support and guaranteed purchase commitments. Policy & Politics: Sint Maarten education and tourism ministers are pushing for earlier, practical cannabis and short-term rental tax responses, while admitting key Airbnb lodging-tax legislation has been stuck in internal review since 2025.
Medical Warning: A new JAMA Insights study says chronic cannabis users with “scromiting” (cannabinoid hyperemesis syndrome) should quit completely, calling sustained abstinence the only sure fix. Heat & Health: A Chicago hospital study links hot weather to more ER visits tied to marijuana-related effects and other health issues. Regulatory Update: Virginia’s HB 30 sets the adult-use retail cannabis framework, with sales starting July 1, 2027 and CCA rules due by Feb. 1, 2027. Retail Expansion: Silly Nice says its products are now in 165 licensed New York dispensaries. Distribution/Compliance: LIX Pet Wellness expands into the Northeast and Mid-Atlantic via Zeigler’s distributor network, pitching THC-free CBD pet products. Enforcement & Crime: RCMP arrested two Air Canada ground employees in Montreal over an alleged cocaine import and cannabis export scheme; in the UK, police seized “drug-laced sweets” in Bristol and courts heard about large cannabis grows and plant seizures. Policy Watch: A federal report urges states to plan now for possible FDA approval of psychedelics, including legal and Medicaid implications.
Sign up for:
CBD Industry News Now
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.